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Polymorphisms in the essential autophagy gene
Atg16L1 have been linked with susceptibility to
Crohn’s disease, a major type of inflammatory bowel
disease (IBD). Although the inability to control intesti-
nal bacteria is thought to underlie IBD, the role of
Atg16L1 during extracellular intestinal bacterial infec-
tions has not been sufficiently examined and com-
pared to the function of other IBDsusceptibility genes,
such as Nod2, which encodes a cytosolic bacterial
sensor.Wefind thatAtg16L1mutantmiceare resistant
to intestinal disease induced by the model bacterial
pathogen Citrobacter rodentium. An Atg16L1 defi-
ciency alters the intestinal environment to mediate
an enhanced immune response that is dependent on
monocytic cells, but this hyperimmune phenotype
and its protective effects are lost in Atg16L1/Nod2
double-mutantmice. These results reveal an immuno-
suppressive function of Atg16L1 and suggest that
gene variants affecting the autophagy pathway may
havebeen evolutionarilymaintained toprotect against
certain life-threatening infections.
INTRODUCTION
An overexuberant response to intestinal bacteria has long been
suspected to underlie inflammatory bowel disease (IBD), yet
demonstrating a causative role for any specific infectious agent
has been challenging. Instead, great emphasis has been placed
on understanding genetic susceptibility, with the hope of identi-
fying pathways that can be targeted for therapeutic intervention.
This effort is exemplified by large-scale population genetic216 Cell Host & Microbe 14, 216–224, August 14, 2013 ª2013 Elsevistudies that have implicated several genes related to autophagy,
a process by which cytosolic material is enclosed in a double-
membrane vesicle and targeted to the lysosome for degradation
and recycling (Hubbard and Cadwell, 2011). Most notably,
several polymorphisms within or near the essential autophagy
gene Atg16L1 increase the risk of acquiring Crohn’s disease,
one of the two major types of IBD (Jostins et al., 2012). As
such, examining the function of Atg16L1 in the complex intesti-
nal environment is likely to yield unique insight into mucosal
immunity and the obscure origin of IBD.
We previously generated mice in which the Atg16L1 locus is
disrupted by a gene trap cassette, leading to reduced Atg16L1
expression and autophagy in all tissues examined (Cadwell
et al., 2008). Upon infection with murine norovirus (MNV), these
Atg16L1 hypomorph (Atg16L1HM) mice develop intestinal abnor-
malities, including aberrant granule formation by Paneth cells, an
intestinal epithelial cell type with antimicrobial function (Cadwell
et al., 2010). This observation in Atg16L1HM mice allowed us to
identify similar Paneth cell defects in Crohn’s disease patients
homozygous for the highly prevalent T300A disease variant of
Atg16L1 (Cadwell et al., 2008). While these results suggest that
Atg16L1 mutation can mediate specific disease manifestations
downstream of an intestinal infection, it is uncertain whether
this susceptibility to a virus can be extended to common
bacterial infections. Moreover, it is unclear why disease variants
ofAtg16L1 and other autophagy genes occur at a high frequency
in the human population if interfering with this pathway increases
susceptibility to intestinal infections.
Nod2, which encodes a cytosolic bacterial sensor, was identi-
fied as a Crohn’s disease susceptibility gene prior to the associ-
ation of autophagy with this disease (Hugot et al., 2001; Ogura
et al., 2001). Nod2/ mice are vulnerable to oral infection with
Citrobacter rodentium, a relative of pathogenic E. coli that
induces many of the histological features associated with IBD
(Kim et al., 2011). Nod2/ mice have impaired recruitment of
monocytes to the intestine in response to C. rodentium due toer Inc.
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B Figure 1. Atg16L1MutantMice Are Resistant
to C. rodentium
(A) Bacteria recovered from stools over time from
WT, Atg16L1HM, and Nod2/mice inoculated with
C. rodentium. Dashed line indicates limit of detec-
tion. n > 10 mice/genotype.
(B) Survival curve of infected mice. n = 16–20 mice/
genotype.
(C) Quantification of weight change for mice in (B)
on day 15 relative to initial body weight.
(D) Quantification of disease for mice in (B) on
indicated days.
(E) Representative H&E-stained colonic sections on
day 15. Yellow double-headed arrow denotes
epithelial hyperplasia, crypt distortion, and goblet
cell depletion, and yellow star indicates region with
marked intramural edema and inflammatory in-
filtrates that focally extend into the muscularis and
serosal surface. Scale bar = 100 mm.
(F) Quantification of pathologies observed in colon.
n = 11–14 mice/genotype.
Data points in (A) and bars in (C) represent median.
Bars in (D) and (F) represent mean. *p < 0.05, **p <
0.01, ***p < 0.001, ****p < 0.0001. Red and black
asterisks in (A) denote significant differences when
comparing Atg16L1HM to WT and Nod2/,
respectively. See also Figure S1.
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Atg16L1 Deficiency Enhances Antibacterial Immunityreduced local production of CCL2, thereby resulting in pro-
longed bacterial shedding and inflammation. In vitro experi-
ments have also shown that activation of Nod2 recruits
Atg16L1 to the site of bacterial entry, a process that can
contribute to autophagy-mediated degradation of E. coli (Coo-
ney et al., 2010; Homer et al., 2010; Lapaquette et al., 2012;
Travassos et al., 2010). However, Atg16L1HM mice display
decreased urinary tract infection by a uropathogenic strain of
E. coli (UPEC), suggesting that this gene has unappreciated
functions in vivo (Wang et al., 2012). In this study, we investi-
gated whether Atg16L1 deficiency wouldmimicNod2 deficiency
and increase susceptibility to C. rodentium.
RESULTS
Atg16L1Deficiency Confers Resistance to C. rodentium
To directly compare Nod2 and Atg16L1 during intestinal infec-
tion, wild-type (WT), Nod2/, and Atg16L1HM mice were orallyCell Host & Microbe 14, 216–22inoculated with 2 3 109 colony-forming
units (cfu) of C. rodentium. Consistent
with previous findings, Nod2/ mice lost
significant body weight, with 50% suc-
cumbing to lethality, and surviving mice
continued to shed bacteria a month after
infection (Figures 1A–1C). However,
Atg16L1HM mice displayed accelerated
clearance with 1,000-fold reduction in
C. rodentium numbers compared to WT
by day 15 (Figure 1A). At this time point,
C. rodentium associated with colonic
tissue was undetectable in 8 out of 12
Atg16L1HM mice compared to 102106
cfu recovered from the same amount oftissue from WT (Figure S1A available online). Similar observa-
tions were made when comparing the amount of bacteria
present in the cecum (Figure S1B). This decrease in intestinal
C. rodentium was not due to an increase in dissemination out
of the gastrointestinal tract, since similar amounts of bacteria
were observed in the spleen and liver of WT and Atg16L1HM
mice (Figures S1C and S1D).
This divergent effect ofNod2 and Atg16L1 deficiency was also
apparent when measuring disease. In contrast to WT and
Nod2/ mice, Atg16L1HM mice displayed 100% survival, and
fewer presented weight loss and diarrheal disease (Figures
1B–1D). Despite susceptibility to virus-mediated pathologies,
Atg16L1HM mice were protected from the inflammatory lesions
and shortening of the colon typically induced by C. rodentium
(Figures 1E, 1F, S1E, and S1F). These results indicate that, in
striking contrast to Nod2, Atg16L1 deficiency confers consider-
able protection from C. rodentium infection and subsequent
disease.4, August 14, 2013 ª2013 Elsevier Inc. 217
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Atg16L1 Deficiency Enhances Antibacterial ImmunityIt is possible that resistance is an indirect effect of Atg16L1
mutation on commensal bacteria, sinceC. rodentium is sensitive
to the composition of other bacteria in the intestine (Ivanov et al.,
2009; Wlodarska et al., 2011). As previously reported (Kamada
et al., 2012), we found that germfree WT mice that lack
commensal bacteria display a high degree of bacterial shedding
with only modest weight loss (Figures S1G and S1H). In compar-
ison, germfree Atg16L1HM mice still had significantly reduced
infection (Figure S1G), indicating that Atg16L1 mutation can
increase resistance in the absence of commensal bacteria.
Atg16L1 could also be required for changes to the epithelium
that are necessary for bacterial adherence, such as cytoskeletal
rearrangement (Mundy et al., 2005). However, such a direct sub-
version of the host machinery is unlikely since Atg16L1 defi-
ciency did not alter the amount of bacteria recovered in an
in vitro binding and infection assay (Figure S1I). Additionally,
WT and Atg16L1HMmice had the same amount of tissue-associ-
ated bacteria earlier on day 6 postinfection (Figure S1F). These
findings indicate that the ability to establish an adherent infection
is not compromised by Atg16L1 mutation and cannot account
for the immense reduction in shedding and tissue-associated
bacteria at later time points.
Atg16L1 Deficiency Is Associated with a Hyperimmune
Transcriptional Response
A previous microarray analysis found that C. rodentium infection
is associated with a large-scale transcriptional response in the
colon that changes over time (Spehlmann et al., 2009). To deter-
mine the effect of Atg16L1 deficiency on this transcriptional
response, we performed RNA deep sequencing (RNA-seq) of
colonic tissue from WT and Atg16L1HM mice on days 0, 6, and
15 postinfection with 3–4 biological replicates per condition.
We identified genes that were differentially regulated by >1.5-
fold (p < 0.05) according to time points (day 0 versus 6 and
day 0 versus 15) and genotype (Figure 2, Table S1). As expected,
bacterial infection of WT mice led to increased expression of
almost all the genes that were identified as top hits in the previ-
ous study (Table S1). While we detected an overlap between WT
and Atg16L1HM samples in the expression of genes that were
induced, many of these changes were genotype specific, and
the overlap was not as pronounced until day 15 postinfection
(Figures 2A and 2B). Remarkably, there were 150 differentially
regulated geneswhen comparing uninfectedWT and Atg16L1HM
mice, 110 of which displayed significantly increased expression
due to Atg16L1 deficiency (Table S1). A substantial proportion of
these genes are associated with type I and II interferons (IFNs),
including those encoding classic markers such as Isg15 and
20-50-oligoadenylate synthetases, signaling molecules (Stat1,
Stat2, Irf9, Irf7), cytokines (Cxcl9 and Ccl5), and IFN-inducible
guanosine triphosphatases (GTPases; Irg, Mx, and GBP family
members). Pathway analysis of this gene set confirmed that
there is an overrepresentation of genes assigned to the func-
tional categories of defense response, innate immunity, antigen
presentation, IFN-inducible GTPase, and response to bacterium
(Figure 2C).
Atg16L1HM mice continued to display this increased expres-
sion of immune-related genes on day 6 postinfection, and there
was also a wound-healing signature that may reflect an acceler-
ated resolution (Figure 2D). In contrast, on day 15 postinfection,218 Cell Host & Microbe 14, 216–224, August 14, 2013 ª2013 ElseviWT mice displayed increased expression of the inflammatory
genes Reg3b, Reg3g, Saa3, Lcn2, and Retnlb relative to
Atg16L1HMmice reflecting the longer disease course (Figure 2E).
Finally, there were numerous examples of antimicrobial genes
that displayed increased expression earlier in Atg16L1HM sam-
ples compared to WT (Figure 2A, Table S1). These results
indicate that the Atg16L1-deficient intestinal environment has a
hyperimmune transcriptional response both prior to and during
C. rodentium infection that is consistent with the accelerated
disease course.
Protection Due to Atg16L1 Mutation Is Independent of
the T Helper Cell Response and Neutrophils
Previous studies have shown that immune responses mediated
by CD4+ T cells, neutrophils, and monocytes are among the
most important during C. rodentium infection (Bry et al., 2006;
Kim et al., 2011; Simmons et al., 2003; Spehlmann et al.,
2009). C. rodentium infection was also previously shown to
induce a T helper 17 (Th17) response that is dependent on
epithelial apoptosis induced by two bacterial virulence factors,
E. coli-secreted effector protein F (EspF) and mitochondrial-
associated protein (MAP) (Torchinsky et al., 2009). However,
we did not detect differences in the amount of epithelial cell
death or number of T cells in colonic sections from infected
WT and Atg16L1HM mice (Figures S2A and S2B). We also
observed similar amounts of lamina propria CD4+ T cells ex-
pressing IFNg, interleukin-17 (IL-17), IL-22, FoxP3, and innate
lymphoid cells (Figures 3A, 3B, and S2C–S2E). Also, Atg16L1HM
mice displayed reduced bacterial numbers compared to WT
when infected by DEspF and DMap bacterial mutants (Fig-
ure S2F and S2G). Although this result suggests that protection
conferred by Atg16L1 deficiency is not specific to C. rodentium,
we previously did not detect enhanced resistance to oral Listeria
monocytogenes infection (Cadwell et al., 2008), and Atg16L1HM
mice did not have enhanced resistance to Yersinia enterocolitica
or pseudotuberculosis (Figures S2H and S2I). Thus, attenuated
strains of C. rodentium are sensitive to Atg16L1 deficiency, but
the enhanced protection displays some pathogen specificity.
Next, we examined whether CD4+ T cells and neutrophils are
essential for the enhanced resistance of Atg16L1HM mice, using
anti-CD4 and anti-Ly6G depleting antibodies, respectively (Fig-
ures S2J and S2K). While 100% of WT mice depleted of CD4+
T cells during infection succumbed to lethality, similarly treated
Atg16L1HM mice were protected from weight loss, and almost
all survived (Figures 3C and 3D). Likewise, neutrophil depletion
significantly increased lethality, weight loss, and bacteria burden
in infected WT, but not Atg16L1HM, mice (Figures 3E, 3F, and
S2L). These results indicate that T helper cells and neutrophils
are dispensable for resistance mediated by Atg16L1 mutation,
despite the essential role of these cell types in WT mice during
infection.
Protection Due to Atg16L1 Mutation Is Dependent
on Monocytes and Nod2
To assess the role of macrophages and their precursor mono-
cytes, infected mice were injected with clodronate liposomes
that deplete this lineage and compared to control mice that
received liposomes only. The specificity of depletion was con-
firmed in both uninfected and infected mice by flow cytometryer Inc.
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Figure 2. Atg16L1 Deficiency Is Associated with a Hyperimmune Transcriptional Response in the Intestine
(A) RNA-seq analysis of whole colonic tissue from WT and Atg16L1HM mice on days 0, 6, and 15 postinfection. Heatmap displays the ratio of normalized
expression values of genes associatedwith immune responses for each sample versusWT on day 0. Right panels show examples of patterns in which expression
is induced in both WT and Atg16L1HM (i and ii), elevated in uninfected Atg16L1HM and remains high (iii and iv), and elevated initially in uninfected Atg16L1HM but
induced in WT after infection (v and vi). Data are shown as counts of RNA base pairs; mean ± SEM.
(B) Venn diagram showing number of genes that display increased expression on day 6 or 15 in Atg16L1HM, WT, or both compared to day 0 samples of the same
genotype.
(C–E) Gene ontology (GO) terms with the highest significance (left) and enrichment (right) are shown. GO analysis of transcripts enriched in Atg16L1HM compared
to WT on day 0 (C), Atg16L1HM compared to WT on day 6 (D), or WT compared to Atg16L1HM on day 15 (E). See also Table S1.
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Atg16L1 Deficiency Enhances Antibacterial Immunity(Figures S3A and S3B). We found that clodronate treatment of
Atg16L1HM mice infected with C. rodentium led to a significant
decrease in survival (Figure 4A). Clodronate liposome injection
in the absence of infection did not cause lethality, indicating
that the survival defect was not due to the treatment itself
(Figure S3C). Also, monocyte depletion increased bacterial
shedding in Atg16L1HM mice to levels similar to that of mono-
cyte-depleted WT mice, both prior to lethality on day 8 and in
survivingmice on day12 (Figures 4B and 4C). These experiments
demonstrate that monocytic cells are essential for the decrease
in disease and bacterial burden due to Atg16L1 deficiency.
Using both flow cytometry and immunohistochemistry (IHC),
we did not detect a difference in the number of intestinal mono-
cytic cells in uninfected WT and Atg16L1HM mice (Figures S3D–
S3G). While C. rodentium infection caused an overall increase,Cell Hosespecially in inflammatory Ly6Chi monocytes, this increase
was similar in WT and Atg16L1HM mice (Figures S3E–S3G).
These results suggest that monocyte function, rather than total
numbers, may be altered in this setting. However, a cell-intrinsic
effect of Atg16L1 deficiency in enhancing monocyte function is
unlikely since autophagy has been shown to contribute to
C. rodentium killing during in vitro infection of peritoneal macro-
phages (Su et al., 2012). We performed a similar experiment and
also found that C. rodentium killing is impaired, rather
than enhanced, in peritoneal macrophages harvested from
Atg16L1HM mice (Figure 4D). To confirm this lack of a cell-
intrinsic role of Atg16L1 in monocytic cells in vivo, we infected
mice with cell-type-specific deletion of Atg16L1 in myeloid cells
generated by breeding mice expressing the Cre recombinase
under the lysozyme M promoter with mice that have at & Microbe 14, 216–224, August 14, 2013 ª2013 Elsevier Inc. 219
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Figure 3. Protection Conferred by Atg16L1
Deficiency Is Independent of the T Helper
Cell and Neutrophil Responses
(A) Quantification by flow cytometry of the total
number of CD4+ T cells (CD4+ TCRb+) in the colonic
lamina propria on day 15 postinfection. n = 4 mice/
genotype. Bars represent mean.
(B) Quantification of the proportion of CD4+ T cells
expressing the indicated differentiation markers after
PMA and ionomycin treatment. n = 9mice/genotype.
Bars represent mean.
(C) Survival curve of infected WT and Atg16L1HM
mice injected with anti-CD4 or isotype control anti-
bodies. n = 6 mice/condition. ***p < 0.001.
(D) Quantification of weight change observed in mice
from (C) on day 13 relative to initial body weight. Bars
represent mean. Error bars represent SEM. *p < 0.05,
**p < 0.01.
(E) Survival curve of infected WT and Atg16L1HM
mice injected with anti-Ly6G or isotype control
antibodies. n = 6 mice/group. **p < 0.01.
(F) Quantification of weight change observed in mice
from (E) on day 8 relative to initial body weight. Bars
represent mean. Error bars represent SEM. ***p <
0.001. See also Figure S2.
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Atg16L1 Deficiency Enhances Antibacterial ImmunityloxP-flanked Atg16L1 allele (Atg16L1fl/fl Lyz-Cre). Atg16L1fl/fl
Lyz-Cre mice did not display differences in bacterial shedding
compared to Atg16L1fl/fl controls (Figure 4E). We also examined
mice with a similar deletion in the Atg16L1-binding partner Atg5
(Atg5fl/fl Lyz-Cre) since these mice display decreased bacteriuria
following bladder infection by UPEC (Wang et al., 2012). Atg5fl/fl
Lyz-Cre mice also did not display altered resistance to
C. rodentium (Figure 4F). These results indicate that Atg16L1
and Atg5 deletion in myeloid cells is not sufficient.
Next, we generated and infected bone marrow chimeras to
differentiate between Atg16L1 function in the hematopoietic
and nonhematopoietic compartments. We found that the recip-
ient Atg16L1HM mice displayed decreased lethality, weight loss,
and bacterial burden regardless of the bone marrow source
when compared to WT recipients reconstituted with WT or
Atg16L1HM bone marrow (Figures 4G, 4H, and S3H). Together
with the above findings, these results indicate that Atg16L1
deficiency in a nonmyeloid cell type mediates enhanced resis-
tance, even though this resistance is dependent on the presence
of monocytes. These results also indicate that the mechanism
by which Atg16L1 deficiency confers resistance toward
C. rodentium in the intestine differs from the mechanism of resis-
tance toward urinary tract infection by the related pathogen
UPEC, which is associated with autophagy in the myeloid
compartment.
Finally, we hypothesized that bacterial recognition by Nod2
would be required for the enhanced protection displayed by
Atg16L1HM mice since Nod2/mice have impaired recruitment220 Cell Host & Microbe 14, 216–224, August 14, 2013 ª2013 Elsevier Inc.of monocytes to the site of bacterial infec-
tion. To test this hypothesis, we generated
Atg16L1HM/Nod2/ double-mutant mice.
As predicted by the monocyte depletion
experiments, the advantage due to
Atg16L1 mutation was lost in the absenceof Nod2. Atg16L1HM/Nod2/ mice displayed degrees of
lethality, weight loss, and bacterial shedding similar to those
seen in Nod2/ mice (Figures 4I, 4J, and S3I). To confirm these
results, we also generated Atg16L1HMmice deficient in the Nod2
signaling adaptor protein Rip2 (Atg16L1HM/Rip2/ mice) and
made similar observations (Figure S3J). These results indicate
that the susceptibility from Nod2 deficiency is dominant over
the benefit of Atg16L1 deficiency.
DISCUSSION
Despite the likely involvement of aberrant host-microbe interac-
tions in the pathogenesis of IBD, the role of Atg16L1 during an
enteric infection has not been sufficiently examined in vivo.
We have found that Atg16L1 mutation leads to significant pro-
tection from C. rodentium infection and the inflammatory intes-
tinal disease caused by this model pathogen. This protection is
independent of a role for Atg16L1 in mediating bacterial adher-
ence or regulating commensal bacteria but is associated with a
hyperimmune transcriptional signature that precedes and con-
tinues during the early part of infection. The degree of resistance
conferred by Atg16L1 deficiency is such that it prevents lethality
in infected mice depleted of CD4+ T cells and neutrophils.
Instead, the enhanced protection provided by Atg16L1mutation
is dependent on monocytes and Nod2. Altogether, our results
indicate that Atg16L1 has an unexpected role in suppressing a
beneficial immune response during an enteric bacterial
infection.
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Figure 4. Resistance to C. rodentium in Atg16L1 Mutant Mice Is Dependent on Monocytes and Nod2
(A) Survival curve of infected WT and Atg16L1HM mice injected with clodronate liposomes or liposomes only (vehicle control). n = 11 mice/group. **p < 0.01.
(B) Quantification of bacteria in stools from mice in (A) on day 8 postinfection. Bars represent median. *p < 0.05, **p < 0.01. n.s., not significant.
(C) Quantification of bacteria in stools from surviving mice in (A) on day 12. Bars represent median. **p < 0.01. n.s., not significant.
(D) C. rodentium was incubated with WT and Atg16L1HM peritoneal macrophages, and internalized bacteria were recovered at indicated time points after
incubation. Average of 3 experiments, n = 6 mice/genotype (2 per experiment). Data points represent mean ± SEM.
(E) Quantification of bacteria recovered from stools over time from Atg16L1f/f and Atg16L1f/fLyz-Cre mice inoculated with C. rodentium. n = 7 Atg16L1f/f and 14
Atg16L1f/fLyz-Cre mice. Data points represent median.
(F) Quantification of bacteria recovered from stools over time from Atg5f/f and Atg5f/fLyz-Cre mice inoculated with C. rodentium. n = 13 Atg5f/f and 11 Atg5f/fLyz-
Cre mice. Data points represent median.
(legend continued on next page)
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Atg16L1 Deficiency Enhances Antibacterial ImmunityGiven the antibacterial function typically attributed to auto-
phagy genes, it is unlikely that Atg16L1 deficiency is beneficial
under all circumstances. Atg16L1HM mice did not display
enhanced resistance when infected by Yersinia species, which
could reflect the difference in strategies used by these patho-
gens and C. rodentium to establish an infection. Both Yersinia
species examined have been shown to efficiently block auto-
phagy-mediated degradation when engulfed by macrophages
(Deuretzbacher et al., 2009; Moreau et al., 2010). It is possible
that Atg16L1 deficiency confers protection toward bacteria
that are less capable of surviving within macrophages and
instead must avoid engulfment for productive infection. Also, it
has become apparent that Atg16L1 and related autophagy
genes have a highly cell-type-specific function. Intestinal epithe-
lium-specific deletion of autophagy genes increases suscep-
tibility, rather than resistance, to C. rodentium and Salmonella
(Benjamin et al., 2013; Inoue et al., 2012). In our experiments,
this adverse effect of autophagy inhibition is masked by the
protective effect of Atg16L1 deficiency, which may explain why
C. rodentium infection led to high lethality in Atg16L1HM mice
following monocyte depletion.
This dependence on monocytes for resistance was somewhat
unexpected since autophagy is important forC. rodentium killing
by monocytic cells in vitro (Su et al., 2012). We found that
Atg16L1 deficiency in monocytic cells in vitro or in vivo did not
lead to enhanced resistance to C. rodentium. Instead, experi-
ments with chimeric mice indicated that Atg16L1 mutation in
the nonhematopoietic compartment mediates enhanced resis-
tance. Nod2 was also shown to function predominantly in the
nonhematopoietic compartment, most likely in stromal cells, in
order to act on monocytes in a cell-extrinsic manner (Kim
et al., 2011). However, unlike in Nod2/mice, monocyte recruit-
ment was not altered in Atg16L1HM mice. In the context of these
findings, it is interesting that we detected a higher expression of
immune-related genes in intestinal tissue harvested from
Atg16L1HM mice. Many of these genes are associated with
IFNs as well as other factors related to activation of monocytic
cells. For these reasons, we favor a model in which Atg16L1
deficiency in the intestinal tissue primes the environment for an
enhanced immune response mediated by monocytes.
The identification ofAtg16L1 andNod2 as susceptibility genes
is frequently cited as evidence that a deficient innate immune
response to bacteria causes Crohn’s disease. The important
role of Atg16L1 and Nod2 in promoting defense against patho-
gens is undeniable. Nevertheless, our findings reveal an immu-
nosuppressive function of Atg16L1 in the intestine that requires
further investigation. If Atg16L1 suppresses a beneficial inflam-
matory response, does it also prevent unnecessary or harmful
responses to enteric infection? This may be the case since, in
our previous study, we found that the same Atg16L1HM mice
develop IBD-related pathologies in response to norovirus infec-(G) Survival curve of chimeric mice inoculated with C. rodentium. n = 10 mice/gr
(H) Quantification of bacteria recovered from stools over time from the mice in (G
denote significant differences comparing WT/WT versus WT/HM (black), HM
versus HM/HM (brown).
(I) Survival curve of WT, Atg16L1HM, Nod2/, and Atg16L1HM/Nod2/ mice ino
(J) Quantification of bacteria from stools over time from the mice in (I). Data points
denote Atg16L1HM compared to Nod2/ and Atg16L1HM/Nod2/, respectively
222 Cell Host & Microbe 14, 216–224, August 14, 2013 ª2013 Elsevition (Cadwell et al., 2010). An exaggerated monocyte response
may be less desirable when the infection is not life threatening.
Our results also indicate that Nod2 and Atg16L1 could have
independent contributions during bacterial infection in addition
to Nod2-mediated autophagy, in which these genes function
together.
Finally, the question has remained as to what selective pres-
sure has led to the maintenance of polymorphisms in Atg16L1
and other autophagy genes that increase the risk of acquiring
inflammatory disorders. C. rodentium has been an important
model pathogen for understanding the immune response to
pathogenic E. coli that causes a range of illnesses, including
pediatric diarrhea, which is often lethal in underdeveloped parts
of the world. Although specific gene variants, such as the prev-
alent T300A allele of Atg16L1 and mutations in the promoter
region of Irgm, require further characterization, it is conceivable
that we have maintained these variants to enhance immunity
during common enteric infections. With our modern lifestyle
that has seen improved sanitation and healthcare, gene variants
that enhance immunitymay have become less of a necessity and
more of a burden that predisposes us to complex inflammatory
disorders.
EXPERIMENTAL PROCEDURES
Mice
All mice were on a C57BL/6 background. High-density microsatellite mapping
(Rheumatic Disease Core, Washington University School of Medicine) was
used for backcrossing previously described Atg16L1HM mice (HM1 strain)
(Cadwell et al., 2008). Nod2/ mice were previously reported (Kim et al.,
2008). Rip2/ mice were from Eric Pamer (Memorial Sloan Kettering Cancer
Center). Atg16L1HM/Nod2/ and Atg16L1HM/Rip2/ mice were generated
by crossing Atg16L1HM and Nod2/ or Rip2/ mice and breeding heterozy-
gous progeny to each other. WT refers to C57BL/6J mice purchased from
Jackson Laboratory that were bred onsite to generate animals for experimen-
tation. Atg5f/f and Atg16L1f/f Lyz-Cre mice were from Skip Virgin (Washington
University School of Medicine). Bone marrow chimeras using Atg16L1HM
donors and recipients (Wang et al., 2012) were infected 8 weeks after transfer,
at which point 96% of the peripheral blood cells were confirmed to be of
donor origin. All animal studies were performed according to approved
protocols by the NYU School of Medicine Institutional Animal Care and Use
Committee (IACUC).
Bacterial Infection
Previously described C. rodentium strain DBS100 and isogenic mutants
DEspF and DMap (Torchinsky et al., 2009) were grown overnight in Luria-
Bertani broth with shaking at 37C and diluted to an optical density of 1
followed by an additional 5 hr of growth. Bacterial density was confirmed by
dilution plating. Gender-matched mice at 8–12 weeks old were inoculated
by oral gavage with 23 109 cfu resuspended in 100 ml PBS. Severity of disease
was quantified through a scoring system in which individual mice received a
score of 1 for each of the following: hunched posture, inactivity, ruffled fur,
and diarrhea. Mice received an additional score between 0 and 2 for weight
loss calculated as percent of initial body weight, with a score of 0 = 0%–5%,
0.5 = 6%–10%, 1 = 11%–15%, 1.5 = 16%–20%, and 2 = greater than 20%oup. *p < 0.05, ***p < 0.001.
). Data points represent median. *p < 0.05, **p < 0.01, ***p < 0.001. Asterisks
/WT versus WT/HM (blue), WT/WT versus HM/HM (red), and HM/WT
culated with C. rodentium. nR 5 mice/genotype. *p < 0.05, **p < 0.01.
represent median. *p < 0.05, **p < 0.01, ***p < 0.001. Blue and green asterisks
. See also Figure S3.
er Inc.
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were weighed, homogenized in PBS, and plated in serial dilutions on
MacConkey agar. Y. psuedotuberculosis (YPIII with pIB1) and enterocolitica
(AJD3) were from Andrew Darwin and prepared similarly with appropriate
antibiotics. The last observation was carried forward for mice that died in
longitudinal studies.
Tissue Collection and Analyses
Hematoxylin and eosin (H&E)-stained colonic sections were prepared as pre-
viously described (Cadwell et al., 2010). Pathology was blindly quantified by a
pathologist (Y.D.) using a previously described scoring system (Asseman et al.,
2003). TUNEL, anti-CD3, and anti-F4/80 staining of colonic sections was per-
formed by the NYU IHC Core. For quantification of tissue-associated bacteria,
2 cm of the distal colon was flushed with PBS and homogenized in PBS. For
cecum, the entire contents were flushed with PBS and homogenized. To
isolate lamina propria cells, small pieces of colons washed with Hank’s
balanced salt solution (HBSS) were incubated at 37C with shaking in HBSS
containing 1 mM dithiothreitol (DTT) and 5 mM EDTA for 15 min, 1 mM
EDTA HBSS for 10 min, washed with HBSS, and then incubated in HBSS con-
taining 0.1 u/ml dispase (Worthington Biochemical), 0.1 mg/ml DNase
(Sigma-Aldrich), and 1mg/ml collagenase (Roche) for 25min. Digested tissues
were filtered and washed twice with RPMI containing 10% fetal calf serum
(FCS). Isolated cells were resuspended in 40% Percoll (Pharmacia Biotech),
layered onto 80% Percoll, and centrifuged at room temperature at
2,200 rpm for 20 min. Cells were recovered from the interphase and washed
with RPMI containing 10% FCS.
Flow Cytometry
Isolated lamina propria cells were stimulated with 10 ng/ml phorbol 12-
myristate 13-acetate and 1 mg/ml ionomycin (Sigma-Aldrich) for 4 hr in the
presence of GolgiStop (Becton Dickinson). After stimulation, cells were trans-
ferred to round bottom 96-well plates and washed twice with MACS buffer
(0.5% w/v BSA, 2.5 mM EDTA in PBS). Cells were resuspended in surface-
stain solution containing Fixable LIVE/DEAD UV (1:500, Invitrogen), anti-
CD4-AF700 (1:200, BD), anti-TCRb-PerCpCy5.5 (1:200, BD), and Fc Block
(1:100, BD). After 15 min, cells were washed twice in MACS buffer, fixed for
20min, washed twice, and resuspended inMACS buffer. For intracellular cyto-
kine staining, cells were permeabilized (0.5% w/v saponin in MACS buffer),
pelleted, then resuspended in intracellular staining solutionmade in permeabi-
lization buffer containing anti-FoxP3-FITC (1:200, BioLegend), anti-iL-17A-
APC (1:200, BD), anti-iFNg-e450 (1:100, BioLegend), anti-iL-22-PE (1:200,
eBioscience), and FC Block (1:100, BioLegend). After 15 min, cells were
pelleted, washed once in permeabilization buffer, once in MACS buffer, then
analyzed by LSR II flow cytometer (BD) gated on live cells. Splenocytes
were stained similarly for surface expression with the following additional
antibodies: anti-Ly6G/C-APC (1:200, BioLegend), anti-F4/80-APC Cy7
(1:200, BioLegend), anti-CD11b-FITC (1:100, BD), and anti-CD11c-PE
(1:200, BD).
In Vitro Killing Assay
Peritoneal exudate cells (PECs) were harvested by lavage with 10 ml
Dulbecco’s modified Eagle’s medium (DMEM) 4 days after mice were injected
intraperitoneally (i.p.) with 1.5 ml thioglycollate, plated, and grown overnight at
37C. PECs were then washed, counted with trypan blue exclusion, plated at
2 3 105 cells per well in 48-well plates, and grown overnight at 37C.
C. rodentium was added at a multiplicity of infection (moi) of 10, and the plate
was centrifuged at 1,000 3 g for 7 min at room temperature. Bacteria were
allowed to bind to cells for 30 min, then DMEM containing 1 mg/ml gentamicin
was added to all wells. Cells harvested at indicated time points were washed
and lysed with 0.1% saponin, and bacteria were quantified by dilution plating.
Statistical Analysis
GraphPad Prism v6 was used for the following. Differences between two
groups were evaluated by two-tailed unpaired t test (Figure 1F). Experiments
that involved multiple comparisons were evaluated by an ANOVA with the
Holm-Sidak test (Figures 1D, 3D, 3F, S1F, S2A, S2D, S2E, S3H, and S3I),
unless values were not distributed normally, in which case the nonparametric
Kruskal-Wallis test with Dunn’s test was applied (Figures 1A, 1C, 4B, 4C, 4H,Cell Hos4J, S1A–S1D, S1G, S2F, S2G, and S2L). Significance was determined after
normalization or transformation when examining weight loss and bacterial
numbers. Survival between groups of mice was compared using the log
rank Mantel-Cox test.
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